Tom Baker Cancer Centre

Tom Baker Cancer Centre is a medical facility located in CALGARY, Alberta. This center is recognized for care of Breast Cancer, Cancer, Prostate Cancer, Lung Cancer, Multiple Myeloma and other specialties. Tom Baker Cancer Centre is involved with conducting 551 clinical trials across 343 conditions. There are 29 research doctors associated with this hospital, such as Prafull Ghatage, MD, Marc Webster, Patricia Tang, and Sonia Cerquozzi, MD.

**Tom Baker Cancer Centre** - **Location:** 1331 29 Street NW, Calgary, Alberta T2N 4N2, within the Foothills Medical Centre. - **Services:** A tertiary care facility serving Southern Alberta, the Tom Baker Cancer Centre offers comprehensive cancer care including prevention, research, treatment programs, and supportive care for both inpatients and outpatients.

**Tom Baker Cancer Centre Contact Information:** - **Financial Assistance:** Patients seeking financial aid can reach the Patient Resource Office at 403-355-3207. This program assists eligible patients by covering certain direct care costs, including travel, accommodations for appointments, and medications not covered by insurance. - **Insurance Inquiries:** For questions related to insurance, please contact the switchboard at 403-355-3207 to be connected to the appropriate department.

The Tom Baker Cancer Centre collaborates with a wide range of insurance providers, including Blue Cross, commercial insurance plans, Medicare, Medicare Part C, Medicaid, U.S. Department of Veterans Affairs, and TRICARE plans. Most cancer treatment drugs are covered, though there may be exceptions. Additionally, the center offers an Outpatient Cancer Drug Benefit Program for those covered by the Alberta Health Care Insurance Plan and registered in the Cancer Registry.

The Tom Baker Cancer Centre, located in Calgary, Alberta, serves as a tertiary care facility for Southern Alberta and is one of two tertiary cancer centers in the province. It specializes in prevention, research, and treatment programs, offering advanced medical and supportive care for both inpatients and outpatients, in collaboration with the Charbonneau Cancer Institute. The center has also been bolstered by a $25 million donation from the Riddell family, aimed at combating treatment-resistant cancers, leading to the establishment of the Riddell Centre for Cancer Immunotherapy.